Skip to main content
PIII logo

PIII · P3 Health Partners Inc.

$10.61 +0.13 (+1.24%)
Market Cap
$75.93M
Shares
7.24M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$1.46B +15.2%
FY2024 Revenue FY2021–FY2024
Net Income
-$147.95M -156.1%
FY2024 Net Income FY2021–FY2024
Operating Margin
-18.53% -5.3pp
FY2024 Operating Margin FY2021–FY2024
Diluted EPS
-$45.26 -43.7%
FY2024 Diluted EPS FY2021–FY2024
Operating Cash Flow
-$91.24M -20%
FY2024 Operating Cash Flow FY2021–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2024 FY2023 FY2022 FY2021
$1.5B – $1.65B $1.47B $1.46B $1.27B $1.05B $491.06M
-$63.08M -$55.03M -$15.99M -$11.4M -$2.53M
$964K $918K $3.23M $5.1M $1.5M
$106.86M $106.31M $122.36M $157.28M $53.39M
$82M $81.9M $84.3M $84.8M $6.96M
$84.19M $84.16M $86.68M $87.29M $795.17K
$1.7B $1.73B $1.43B $2.61B $519.65M
-$223.98M -$270.3M -$167.93M -$1.56B -$28.59M
-18.53% -13.26% -148.73% -5.82%
-$139.79M -$186.14M -$81.26M -$1.47B -$27.79M
-$61.87M -$50.76M -$15.8M $1.22M -$2.82M
-$285.85M -$321.06M -$183.73M -$1.56B -$31.41M
-$10.05M $2.03M $2.7M $1.86M $0
-$126.25M -$147.95M -$57.77M -$270.13M -$31.41M
-10.14% -4.56% -25.74% -6.4%
-$149.56M -$175.14M -$128.65M -$1.29B -$47.86M
-$268.75M -$270.13M -$10.08M
USD/shares -$45.26 -$30.50 -$325.00 -$12.00
USD/shares -$45.26 -$31.50 -$325.00 -$12.00
shares 3.27M 1.9M 831.58 831.58K
shares 3.27M 5.89M 831.58 831.58K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
0.25×
Peer median 0.86×
EV/EBIT
P/E (TTM)
Peer median 5.42×

Peer medians compare against the 21 similar-size Medical Care Facilities companies (of 57 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023
Single Reportable Segment $1,459,080,000 $1,500,455,000 $1,266,375,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2020 FY2019
Capitated Revenue $1,428,979,000 $1,483,602,000 $1,252,309,000 $1,034,800,000 $480,739,577 $139,332,707
Health Care Patient Service $30,101,000 $16,853,000 $14,066,000 $14,671,000 $10,323,948 $6,149,405
Health Care Incentive Fees $16,222,000 $356,000 $573,000 $238,000
Health Care Care Coordination Management Fees $10,823,000 $10,563,000 $8,301,000 $7,924,000
Health Care Clinical Fees Insurance Revenue $3,056,000 $5,934,000 $5,192,000 $6,158,000
Health Care Shared Risk Revenue $0 $351,000
Key facts CIK 1832511 CUSIP 744413204 13F (30d) 2 filings 2 filers Visit website Investor relations